JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.14% |
| 2 | Technology | 13.12% |
| 3 | Financials | 12.1% |
| 4 | Healthcare | 9.54% |
| 5 | Consumer Discretionary | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SCHW
101
Charles Schwab
SCHW
$167B
| $1.17B | 0.22% |
24,515,917
+5,182,589
| +27% | +$228M |
2013 Q2
26 quarters
|
|
102
Intuitive Surgical
ISRG
$150B
| $1.16B | 0.22% |
5,869,575
-105,654
| -2% | -$19.8M |
2013 Q2
26 quarters
|
|
103
Dover
DOV
$25.5B
| $1.14B | 0.21% |
9,848,083
+439,123
| +5% | +$47M |
2013 Q2
26 quarters
|
|
104
Ventas
VTR
$42.1B
| $1.07B | 0.2% |
18,537,079
+1,866,189
| +11% | +$117M |
2013 Q2
26 quarters
|
|
105
Tesla
TSLA
$1.51T
| $1.06B | 0.2% |
38,063,985
+32,698,995
| +609% | +$709M |
2013 Q2
26 quarters
|
|
106
AutoZone
AZO
$47B
| $1.04B | 0.19% |
869,089
-114,679
| -12% | -$132M |
2013 Q2
26 quarters
|
|
107
US Bancorp
USB
$88.3B
| $1.03B | 0.19% |
17,349,527
-755,506
| -4% | -$43.7M |
2013 Q2
26 quarters
|
|
108
CALL
Invesco QQQ Trust
QQQ
$506B
| $1.02B | 0.19% |
4,812,400
-704,800
| -13% | -$141M |
2013 Q2
26 quarters
|
|
109
Vanguard Morningstar Mid-Cap ETF
VO
$106B
| $1.02B | 0.19% |
22,832,656
+1,336,328
| +6% | +$57.4M |
2013 Q2
26 quarters
|
|
110
iShares MBS ETF
MBB
$35.5B
| $1.01B | 0.19% |
9,336,482
+519,488
| +6% | +$56.1M |
2013 Q2
26 quarters
|
|
111
Ross Stores
ROST
$71.2B
| $1B | 0.19% |
8,605,215
-1,283,058
| -13% | -$144M |
2013 Q2
26 quarters
|
|
112
Northrop Grumman
NOC
$68.7B
| $971M | 0.18% |
2,822,367
+298,297
| +12% | +$105M |
2013 Q2
26 quarters
|
|
|
PXD
113
DELISTED
Pioneer Natural Resource Co.
PXD
| $969M | 0.18% |
6,401,984
-739,393
| -10% | -$98.4M |
2013 Q2
26 quarters
|
|
114
CALL
SPDR Gold Trust
GLD
$142B
| $968M | 0.18% |
6,774,600
+1,980,300
| +41% | +$277M |
2014 Q3
21 quarters
|
|
115
Union Pacific
UNP
$165B
| $957M | 0.18% |
5,292,515
-411,760
| -7% | -$70.5M |
2013 Q2
26 quarters
|
|
116
Loews
L
$21.9B
| $956M | 0.18% |
18,222,422
+685,766
| +4% | +$34.6M |
2013 Q2
26 quarters
|
|
117
Prudential Financial
PRU
$39B
| $956M | 0.18% |
10,202,820
+834,895
| +9% | +$76.7M |
2013 Q2
26 quarters
|
|
118
Synopsys
SNPS
$97.5B
| $954M | 0.18% |
6,851,640
-229,008
| -3% | -$31.4M |
2013 Q2
26 quarters
|
|
119
Marathon Petroleum
MPC
$131B
| $945M | 0.18% |
15,689,492
-1,845,476
| -11% | -$115M |
2013 Q2
26 quarters
|
|
120
Becton Dickinson
BDX
$49.7B
| $943M | 0.18% |
3,554,163
-964,074
| -21% | -$240M |
2013 Q2
26 quarters
|
|
121
iShares Core Dividend Growth ETF
DGRO
$42.9B
| $936M | 0.17% |
22,243,295
+1,183,805
| +6% | +$47.9M |
2016 Q2
14 quarters
|
|
122
Chubb
CB
$132B
| $935M | 0.17% |
6,009,355
-793,142
| -12% | -$121M |
2013 Q2
26 quarters
|
|
123
Travelers Companies
TRV
$76.9B
| $921M | 0.17% |
6,728,185
-366,686
| -5% | -$49.9M |
2013 Q2
26 quarters
|
|
124
M&T Bank
MTB
$31.3B
| $921M | 0.17% |
5,427,150
-154,646
| -3% | -$25.1M |
2013 Q2
26 quarters
|
|
125
S&P Global
SPGI
$120B
| $919M | 0.17% |
3,364,748
-344,845
| -9% | -$89.6M |
2016 Q2
14 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.